NOCM
IDXX icon

Night Owl Capital Management’s Idexx Laboratories IDXX Stock Holding History

Night Owl Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,588
Closed -$7.79M – 29
2020
Q4 		$7.79M Buy
15,588
+215
+1% +$96.2K 1.5% 23
2020
Q3 		$6.04M Sell
15,373
-20
-0.1% -$7.39K 1.26% 24
2020
Q2 		$5.08M Sell
15,393
-23
-0.1% -$6.66K 1.21% 23
2020
Q1 		$3.73M Buy
+15,416
New +$4.02M 1.25% 21

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Night Owl Capital Management's IDXX Position: Q1 2021 in Review

Night Owl Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 15,588 shares — an estimated $7.79M sold.

Night Owl Capital Management first reported a position in IDXX in Q1 2020 and held it in 4 quarters. The position peaked at $7.79M in Q4 2020. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

  • Night Owl Capital Management reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
  • Night Owl Capital Management sold 15,588 Idexx Laboratories shares in Q1 2021, an estimated $7.79M.
  • Night Owl Capital Management first reported a position in Idexx Laboratories in Q1 2020 and held it in 4 quarters.
  • Night Owl Capital Management's Idexx Laboratories position peaked at $7.79M in Q4 2020.
  • 1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Night Owl Capital Management's 13F filing for Q1 2021, filed 14 May 2021.